Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Polyvalent vaccine reported to improve survival in advanced melanoma

June 18, 2004

Pivotal phase III trial of Rencarex for renal cell carcinoma opens enrollment

June 17, 2004

Synergistic effects of IL-21 and rituximab in B-lymphoma cell lines

June 17, 2004

An EGF vaccine reported to improve survival in advanced lung cancer

June 17, 2004

Antitumor effects of CpG-7909 in several types of human cancer

June 17, 2004

Autologous Xcellerated T-cells show antitumor efficacy in phase I/II clinical trials

June 16, 2004

Preliminary data suggest epratuzumab plus rituximab is safe and effective in NHL

June 16, 2004

Phase I/II study for Merix's renal cancer vaccine

June 15, 2004

New data on the use of SC-1 in the treatment of gastric cancer

June 15, 2004

Genzyme researchers claim antigenic gp100 peptides and their use as cancer vaccines

June 14, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...